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Abstract
Sleep consumes a third of our lifespan, but we are far from understanding how it is initiated, 
maintained and terminated, or what purposes it serves. To address these questions, alternative 
model systems have recently been recruited. The diurnal zebrafish holds the promise of bridging 
the gap between simple invertebrate systems, which show little neuroanatomical conservation with 
mammals, and well-established, but complex and nocturnal, murine systems. Zebrafish larvae can 
be monitored in a high-throughput fashion, pharmacologically tested by adding compounds into 
the water, genetically screened using transient transgenesis, and optogenetically manipulated in a 
non-invasive manner. Here we discuss work that has established the zebrafish as a powerful system 
for the study of sleep, as well as novel insights gained by exploiting its particular advantages.
Why zebrafish?
By the start of this century, the zebrafish was a well-established model for developmental 
studies. As has often been the case for model systems, the use of zebrafish has recently 
expanded from studies of development to behavior. Zebrafish are vertebrates whose nervous 
system and neuropharmacology is highly conserved with that of mammals. Crucially for the 
study of sleep, zebrafish are diurnal, similar to humans, and unlike commonly used murine 
systems. The generation time of zebrafish is similar to that of mice, and more genetic tools 
are currently available for mouse studies, but the power of zebrafish comes from the ability 
to work with larvae, as opposed to adults. A single zebrafish mating routinely provides 200–
300 embryos, which by the 5th day of development have developed into independent larvae 
that exhibit robust wake/sleep cycles (Box 1). The small size (~4 mm) of these larvae 
enables their behavior to be tracked in 96-well plates (Figure 1A), allowing for robust 
statistical analysis. Furthermore, the advantages that make zebrafish an excellent 
developmental model system (external development, optical transparency, facile transgenesis 
and drug administration) are also applicable and useful in the study of the development and 
function of sleep circuits. Thus, zebrafish complement more established model systems for 
the study of sleep by straddling the gap between simple and efficient invertebrate model 
systems, and more expensive and demanding mammalian models. Here we focus on recent 
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contributions of zebrafish to our understanding of sleep regulation, with a focus on work that 
highlights the particular advantages of this system.
Box 1
Sleep in zebrafish
The gold standard for determining and quantifying sleep states in mammals has been the 
combination of electroencephalography (EEG) and electromyography (EMG); specific 
EEG profiles correlate with different sleep states, while REM sleep is characterized by 
lack of muscle tone. These approaches are not practical for the small zebrafish larvae, or 
for invertebrate model systems. Instead, researchers rely on 3 behavioral criteria to 
differentiate sleep from inactivity. (1) Behavioral quiescence. This state must be rapidly 
reversible, thus distinguishing it from paralysis or coma, and is usually regulated by the 
circadian clock. (2) Increased arousal threshold. In contrast with awake but inactive 
animals, sleeping animals require stimuli of higher intensity to respond at the same 
frequency as awake animals. (3) Homeostatic control. Sleep pressure increases with 
time spent awake, and following sleep deprivation there is an increase in sleep duration to 
compensate for lost sleep. Zebrafish larvae satisfy all three criteria: most sleep occurs 
during the dark phase of the circadian cycle [70], and larvae exhibit increased arousal 
threshold after 1 or more minutes of inactivity [21••], as well as sleep rebound after sleep 
deprivation caused by either mechano-acoustic stimulation [2••] or by constant water 
flow [71].
Although these behavioral criteria have been used to demonstrate that zebrafish larvae 
sleep, the lack of a real-time indicator of sleep, such as the EEG/EMG combination used 
in mammalian systems, presents significant challenges. Until a real-time reporter of sleep 
states is developed for zebrafish larvae, the community must be careful in interpreting 
locomotion-based results. Such precautions include common good scientific practices 
such as using a variety of approaches (genetics, pharmacology, direct manipulation of 
neuronal activity), using arousal threshold assays, investigating the interactions of 
potential novel sleep systems with previously established sleep centers, as well as 
comparing zebrafish results with studies in other vertebrate and invertebrate systems.
Melatonin
Similar to mammals, melatonin in zebrafish is produced by the pineal gland at night, under 
the control of the circadian clock [1]. Administration of exogenous melatonin was shown to 
induce sleep in larval zebrafish [2••] similar to humans [3], in the first demonstration of 
conservation of sleep regulation between zebrafish and humans at the molecular level. In the 
same seminal study [2••], it was also demonstrated that rest in zebrafish larvae fulfills the 
behavioral criteria of sleep (Box 14), thus establishing zebrafish as a sleep model. Although 
melatonin is produced at night (rest period) in diurnal animals such as humans and zebrafish, 
it is also produced at night (active period) in nocturnal rodents [4]. Melatonin has a sleep-
promoting effect in several diurnal species, including humans [3,5], but does not induce 
sleep in nocturnal animals [3]. These observations suggest that nocturnal animals are not 
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ideal models to understand how melatonin regulates sleep in diurnal vertebrates such as 
humans. Further complicating matters, most commonly used laboratory mouse strains do not 
produce melatonin [4] (melatonin promotes seasonal reproduction patterns, so as wild mice 
strains were adapted to the lab there was presumably an unintended selection for melatonin 
deficient mutants). This makes zebrafish a particularly attractive system for investigating the 
role of melatonin in sleep.
Historically, the main avenue for depletion of endogenous melatonin had been pinealectomy, 
a crude technique likely to produce artifacts due to its invasiveness, variability among labs 
and different species, and uncharacterized, melatonin-independent roles of the pineal gland 
in animal physiology. Recently however, considerable progress in clarifying the function of 
melatonin in sleep was made using genetics with zebrafish containing a null mutation in 
arylalkylamine-N-acetyltransferase (aanat2), the rate-limiting enzyme in melatonin 
biosynthesis [6••]. aanat2−/− larvae show dramatically reduced sleep at night, but normal 
sleep during the day, demonstrating a clear role for endogenous melatonin in promoting 
nighttime sleep in a diurnal vertebrate. Importantly, behavioral and molecular circadian 
rhythms are normal in aanat2−/− fish, suggesting that melatonin is not required for the 
establishment or maintenance of normal circadian rhythms, but rather acts downstream of 
the circadian clock. Endogenous melatonin has been proposed to regulate sleep indirectly by 
impinging upon the circadian clock, either by phase shifting [7] or by inhibiting the 
circadian drive for wakefulness [8]. However, when raised under constant dark conditions, in 
which behavioral and molecular circadian rhythms are absent [9], aanat2−/− larvae maintain 
their decreased sleep phenotype [6••], suggesting that melatonin promotes sleep 
independently of the clock. Rather, melatonin appears to determine when sleep occurs 
during the circadian cycle. Indeed, aanat2−/− larvae raised in normal light/dark conditions, 
and transferred to constant dark to remove the masking effects of light on sleep behavior, 
lose all sleep rhythmicity but maintain locomotor and molecular rhythms [6••]. This striking 
observation indicates that melatonin is required for circadian regulation of sleep, suggesting 
that it is the key factor that mediates process C [10], that is, the circadian gating of sleep 
(Figure 2). It will be interesting to repeat this series of experiments in a diurnal mammal to 
investigate whether these observations are specific to zebrafish or apply broadly to diurnal 
vertebrates.
Hypocretin
The neuropeptide hypocretin (Hcrt) is an important regulator of arousal [11]. Hcrt is 
expressed in thousands of neurons in the mammalian lateral hypothalamus [12,13] that 
project to arousal centers throughout the brain [14]. In mammals, loss of Hcrt expressing 
neurons results in narcolepsy [15–17], whereas activation of these neurons promotes sleep to 
wake transitions [18], demonstrating the crucial role of Hcrt in sleep regulation. Hcrt has 
been of particular importance for zebrafish sleep research. It was initially the subject of 
proof-of-principle studies that sought to establish zebrafish as a useful model system for the 
genetic dissection of sleep. More recently, the zebrafish has returned the favor by providing 
novel insights into how Hcrt neurons are generated, and how Hcrt promotes wakefulness.
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Hcrt research in zebrafish began with genomic and anatomical studies demonstrating 
conservation between zebrafish and mammals. Zebrafish have a single hcrt homolog [19] 
that is expressed in a small hypothalamic population (~ 10 cells) starting around 24 hours of 
development [20,21]. In larvae, Hcrt expressing cells send widespread ascending and 
descending projections throughout the brain, including projections to areas associated with 
arousal, such as the noradrenergic locus coeruleus (LC) and dopaminergic diencephalic 
cells, areas which also express the hypocretin receptor (hcrtr) [21••]. An early study showed 
sleep fragmentation for hcrtr−/− adult zebrafish, similar to narcoleptic mammals, but also 
claimed that Hcrt has a sleep-promoting role in zebrafish [22•]. Since then, extensive work 
has established a wake-promoting role for Hcrt in zebrafish, similar to mammals. First, 
overexpression of hcrt in larvae using a heat-shock inducible promoter results in increased 
locomotor activity, consolidation of active states, and reduced sleep [21••]. Second, a 
recently developed high-throughput and non-invasive optogenetic assay demonstrated that 
stimulation of Hcrt neurons increases locomotor activity (Figure 1C) in a hcrtr dependent 
manner [23••], consistent with the arousing effect of optogenetic stimulation of Hcrt neurons 
in mice [18]. Third, chemogenetic stimulation of Hcrt neurons, again in freely-behaving 
zebrafish larvae, using the capsaicin-activated TRPV1 channel increases activity and reduces 
sleep [24•]. Fourth, real-time monitoring of the activity levels of Hcrt neurons in freely 
behaving zebrafish larvae revealed that Hcrt neurons are wake active, similar to previous 
findings in rats and mice [25–27]. Finally, ablation of Hcrt neurons in zebrafish larvae 
results in increased and fragmented sleep [24•,28], reminiscent of narcolepsy 
endophenotypes.
Zebrafish research has recently provided insights into how Hcrt neurons are generated and 
how they promote arousal. The transcription factor Lhx9 was shown to be required for the 
specification of Hcrt neurons in mice, with lhx9−/− animals having reduced numbers of Hcrt 
neurons and sleeping more than sibling controls [29]. Starting from a list of transcripts 
enriched in zebrafish Hcrt neurons, Lhx9 was independently shown to be necessary for Hcrt 
neuron specification in zebrafish larvae [30•]. In addition, overexpression of lhx9 in 
zebrafish larvae resulted in the generation of ectopic Hcrt neurons that express appropriate 
molecular markers and project to the LC, similar to entopic Hcrt neurons. lhx9 
overexpression in embryonic mice, using in utero electroporation, also resulted in 
specification of additional Hcrt neurons, suggesting that the function of Lhx9 in specifying 
Hcrt neurons is conserved between fish and mammals [30•]. Interestingly, the hcrt promoter 
contains Lhx9 binding sites that are essential for hcrt expression and can be bound by Lhx9 
in vitro [30•]. These results suggest that Lhx9 both specifies Hcrt neuron identity and 
directly promotes hcrt expression.
Hcrt neurons project to the LC [14], and arousal induced by optogenetic stimulation of Hcrt 
neurons is suppressed by optogenetic silencing of LC neurons in rodents [31], suggesting 
that norepinephrine (NE), the main neurotransmitter of the LC, could be a critical mediator 
of Hcrt-induced arousal. Despite abundant pharmacological evidence for a role for NE in 
arousal [32], the role of endogenous NE had been unclear, as mice mutant for dopamine 
beta-hydroxylase (dbh), the rate limiting enzyme in NE biosynthesis, display developmental 
defects and have produced conflicting reports on the role of NE in sleep [33,34]. In contrast, 
dbh−/− zebrafish larvae develop normally, are viable and fertile, and show a dramatic 
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increase in sleep [23••], thus establishing a role for endogenous NE in sleep regulation. 
Importantly, insomnia induced by Hcrt overexpression or optogenetic stimulation of Hcrt 
neurons was suppressed in dbh−/− larvae, demonstrating that endogenous NE is required for 
the arousing effects of Hcrt [23••].
The zebrafish pineal gland expresses hcrtr and is also innervated by Hcrt neurons [35], 
similar to mammals [36–38]. Interestingly, application of Hcrt on cultured pineal glands 
increases melatonin production, while hcrtr−/− adult zebrafish show reduced expression of 
aanat2. Combined with the observation that Hcrt is present during the night [39], these 
results suggest a role for Hcrt in consolidating nighttime sleep by inducing melatonin 
production during the night, and could explain the sleep fragmentation phenotype of hcrtr−/− 
zebrafish [22•].
Pharmacology
Larval zebrafish are particularly well suited for small molecule screens and pharmacological 
studies in general: they are small enough to be screened in 96-well plates in an automated 
fashion, and compounds are simply added to the water and taken up through the skin and 
gills [40]. The blood-brain barrier is not fully formed at larval stages [41], thus bypassing a 
major hurdle in CNS accessibility, and the larvae can survive several days using nutrients 
supplied by the yolk, with no need for feeding. Indeed, much of the early work on zebrafish 
sleep was based on pharmacological approaches using known sleep regulators such as 
melatonin [2••], histamine [42,43] and GABA [43].
In the first, and still most comprehensive, screen for sleep regulating compounds in a 
vertebrate animal, the effects of over 5,000 small molecules on locomotion and sleep 
architecture were evaluated in zebrafish larvae [44••]. This study demonstrated conserved 
roles for multiple signaling molecules in sleep regulation (glutamate, GABA, 
norepinephrine, serotonin, dopamine, histamine, adenosine, melatonin), setting the stage for 
the use of zebrafish as a model system for investigating the role of these and other 
neurotransmitters and neuropeptides in sleep regulation. By assigning a behavioral 
fingerprint to each compound, and using clustering algorithms to group compounds that 
induce similar behavioral profiles, potential targets were assigned to previously 
uncharacterized molecules, and novel pathways with potential sleep-regulating roles were 
uncovered [44••]. Further studies have used zebrafish to investigate how clinically used 
hypnotics and psychostimulants impinge upon sleep architecture [45,46].
Progress in understanding sleep regulation has the potential to provide insights into several 
neurological diseases, including autism spectrum disorders (ASDs), which are associated 
with hyperactivity and sleep disruption [47]. Zebrafish mutant for the two paralogs of 
contactin associated protein-like 2 (CNTNAP2), a gene strongly associated with ASD [48], 
display hyperactivity during the night [49••], as does the mouse knockout [48]. The 
availability of a database containing the behavioral fingerprints of thousands of drugs in 
zebrafish larvae [44••] enabled the identification of compounds that generate phenotypes 
correlating and anti-correlating with those of the cntnap2ab mutants [49••]. Drugs with 
known estrogenic activity were found among the top anti-correlating compounds, suggesting 
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that such compounds could potentially rescue the cntnap2ab mutant phenotype. Indeed, 
biochanin A and β-estradiol were shown to specifically, and acutely, rescue the hyper-
activity phenotype [49••]. This study suggests a potential molecular mechanism for the 
“female protective model” [50] and raises hopes for the eventual development of ASD 
treatments based on estrogen signaling.
New approaches and genetic pathways
An implicit promise of a novel model system is the potential to provide insights by opening 
up new avenues of addressing old questions, as well as to uncover novel genetic pathways. 
The zebrafish has lived up to expectations on both fronts.
Mice mutant for dopamine beta-hydroxylase (dbh) display embryonic lethality and require 
supplementation with a NE precursor during development in order to survive [51]. As adults, 
these animals have produced conflicting reports on the role of NE in sleep [33,34]. In 
contrast, dbh−/− zebrafish larvae develop normally without the need for exogenous NE 
supplementation, and show a dramatic increase in sleep [23••] (Figure 1A). Interestingly, 
dbh−/− zebrafish larvae also show a severely reduced arousal threshold (Figure 1B), a 
phenotype that was replicated by pharmacologically blocking beta-adrenergic receptor 
signaling, but not through pharmacological manipulation of alpha1- or alpha2-adrenergic 
signaling. Although it is surprising that reduction of an arousal-promoting neurotransmitter 
results in reduced arousal threshold, NE reuptake inhibitors such as atomoxetine are 
commonly used as a treatment for Attention Deficit/Hyperactivity Disorder [52], presumably 
reducing hyper-excitability by increasing NE levels. In another case of a developmental 
phenotype potentially masking sleep phenotypes, mice mutant for one of the two receptors 
for the hypothalamic neuropeptide QRFP showed severe bone formation defects [53] (the 
effects of mutating the other receptor or qrfp have not been reported). Zebrafish mutant for 
both QRPF receptors (grp103a and grp103b) show no obvious developmental defects; 
instead grp103a−/−; grp103b−/− double mutant larvae are more active and sleep less than 
sibling controls, suggesting a sleep promoting role for QRFP [54•]. Indeed, overexpression 
of QRFP reduces activity in a grp103a; grp103b dependent manner [54•]. It is worth noting 
that previous studies in nocturnal rodents based on intracerebroventricular (ICV) injection of 
peptides derived from QRFP gave conflicting reports, with some suggesting a locomotion-
promoting role [55,56] and some finding no significant effect on locomotion [57,58]. 
However, these studies were based on invasive ICV injection of in vitro synthesized 
peptides, as opposed to genetic loss-of-function studies, a significant caveat when 
interpreting these results.
A common theme in the above zebrafish studies is the lack of deleterious phenotypes in 
zebrafish mutants compared to mice with mutations in the homologous genes. The common 
ancestor of teleosts underwent an additional round of genome duplication compared to other 
vertebrates, known as the teleost-specific genome duplication (TSD) [59]. It is thus possible 
that the narrower range of phenotypes observed in dbh−/− and grp103a−/−; grp103b−/− 
mutants is due to the presence of functionally redundant TSD-generated paralogs. However, 
despite a fully sequenced genome [60], such paralogs have not been detected, and in the case 
of dbh−/− larvae, the lack of NE was verified by ELISA [23••]. It has been hypothesized that 
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dbh−/− mice die in utero due to hypoxia caused by defects in heart development [61]. 
Supplementation of parental diet with dihydroxyphenylserine (DOPS), which can be 
converted to NE independently of DBH, during embryonic development rescues dbh−/− 
pups, and is not required postnatally. Zebrafish larvae develop externally, supported by 
nutrients received from the yolk sac, and receive adequate oxygenation by diffusion in the 
absence of normal heart function [62], which may allow zebrafish mutants to bypass this 
critical developmental window. Finally, developing zebrafish do not require maternal care or 
other complex social interactions between parents and offspring that are essential for 
mammalian development, thus avoiding a cause of perinatal lethality and poor development 
in some mouse mutants. For example, it has been shown that even dbh+/− pups born to 
dbh−/− mothers have increased mortality due to deficits in maternal care [51].
Different approaches have been used to identify new genes involved in sleep regulation 
using zebrafish. In a recent study, Hcrt neurons were purified from zebrafish Tg(hcrt:EGFP) 
larvae by flow cytometry, and their transcriptional profile was analyzed by RNA-seq [63•]. 
Candidate genes that showed high expression in Hcrt neurons were anatomically verified 
using in situ hybridization or immunofluorescence, techniques that are particularly well 
suited to the small and optically transparent zebrafish larvae. Among the verified genes was 
the voltage-gated potassium channel kcnh4a, which was shown to be expressed in all Hcrt 
neurons [63•]. kcnh4a−/− mutants demonstrated mild hyperactivity during the day, and a 
more robust reduction in nighttime sleep, thus establishing Kcnh4a as a novel sleep-
regulating channel [63•].
Forward genetic screens in which the progeny of mutagenized parents are screened for 
phenotypes of interest have been instrumental in the establishment of zebrafish as a model 
system for the study of development and simple behaviors [64,65]. More recently, a forward 
genetic screen provided interesting insights into habituation learning [66]. However, such an 
approach for the study of sleep presents several challenges. Sleep is a long-term state and 
thus requires assays that last for several days. Also, similar to humans, even closely related 
zebrafish larvae exhibit considerable variability in sleep/wake behaviors, with phenotypes 
apparent only at the population level. Furthermore, subtle developmental defects can give 
rise to locomotion phenotypes that can easily be misinterpreted as sleep phenotypes. To 
avoid these issues, a candidate approach using an inducible system was recently employed 
[67••]. Genes predicted to encode human secreted peptides were cloned downstream of heat-
shock inducible elements and injected into zebrafish embryos, giving rise to transient 
transgenic larvae, which were subsequently assayed for locomotion and sleep phenotypes. 
By comparing behavior before and after heat-shock in the same animals, the authors were 
able to rapidly screen over a thousand genes that encompass one-third of the human 
secretome without affecting development, and without the need to produce stable transgenic 
lines. Over-expression of the neuropeptide neuromedin U (Nmu) was shown to induce a 
dramatic increase in locomotion, and a concomitant decrease in sleep, with both phenotypes 
depending upon nmu receptor 2; conversely, nmu−/− larvae and adults displayed reduced 
activity [67••]. Interestingly, the Nmu overexpression phenotype correlated with activation 
of brainstem corticotropin releasing hormone (crh) neurons and was blocked by a CRH 
receptor 1 antagonist, suggesting a novel hypothalamus to hindbrain neuronal and genetic 
circuit that promotes arousal [67••].
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More targeted candidate approaches can also be used. In a recent study, the effects of the 
overexpression of seven neuropeptides on different arousal modalities was assayed, again 
using a heat-shock inducible system [68]. By subjecting larvae to a variety of stimuli 
(mechano-acoustic, visual, thermal), the authors were able to dissect the contributions of 
different arousal systems on different aspects of sensory responsiveness. For example, 
compared to sibling controls, Hcrt-overexpressing larvae showed a striking increase in their 
response to a dark-flash stimulus, but no significant changes in their response to mechano-
acoustic or heat stimuli [68]. These results suggest the existence of multiple arousal-
regulating systems dedicated to different sensory inputs. Identifying the neuronal and 
molecular nature of such regulators, and their specializations, could help to deconstruct a 
general state of reduced arousal, such as sleep, down to its building blocks.
What lies ahead
As sleep research moves from genes to neuronal circuits, zebrafish larvae offer a powerful 
system for such inquiries. Advances in light-sheet microscopy allow whole-brain functional 
imaging of zebrafish larvae at cellular resolution using genetic reporters of neuronal activity 
such as GCaMP6 [69••]. By combining this imaging approach with the pharmacologic, 
genetic, optogenetic and chemogenetic tools featured in the studies outlined here, zebrafish 
provide an opportunity to identify novel sleep-regulating circuits and investigate how they 
interact with known sleep centers. The ability to visualize and manipulate these neurons in 
real time will allow us to understand the choreography of sleep: how animals enter sleep, 
how the sleep state is maintained and how it is reversed. Once we truly understand how, we 
can start offering educated guesses as to why, thus moving closer to unraveling the 
fascinating mystery that is sleep.
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Highlights
• Zebrafish research has offered novel insights into sleep regulation.
• Melatonin is required for circadian regulation of sleep.
• Lhx9 regulates Hcrt cell fate, and norepinephrine mediates Hcrt-induced 
arousal.
• QRFP and Kcnh4 are novel sleep regulators identified by zebrafish research.
• High-throughput tracking, optogenetics and whole-brain imaging promise 
further discoveries.
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Figure 1. Common zebrafish sleep assays: Monitoring locomotor activity and sleep, determining 
arousal threshold and quantifying results of optogenetic manipulations
(A) Quantification of locomotor activity and sleep. Zebrafish larvae are housed in wells of a 
96-well plate and their activity is monitored using an infrared camera, giving rise to 
locomotor activity and sleep graphs. In this example, animals lacking endogenous 
norepinephrine due to a mutation in dopamine beta-hydroxylase (dbh) show reduced activity 
and increased sleep. (B) Determining arousal threshold. The response of larvae to mechano-
acoustic stimuli of varying intensities is quantified, and a stimulus-response curve is 
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constructed in order to determine the tapping power at which 50% of the maximal response 
is achieved (Effective Tap Power 50, ETP50). dbh−/− animals show a reduced arousal 
threshold (ETP50 = 2.1 for dbh−/− vs. 3.1 for dbh+/+ sibling control). a.u. = arbitrary units. 
(C) Optogenetic manipulation of neuronal activity. Upon exposure to ambient blue light 
during the dark phase (blue-shaded area), all larvae respond with an acute startle, followed 
by near return to baseline and finally a lasting increase in locomotion as they adapt to the 
new light conditions. Animals expressing ChR2 in Hcrt neurons show a significantly 
enhanced response compared to sibling controls throughout the trial.
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Figure 2. The two-process model of sleep regulation
Sleep is regulated by homeostatic drive (Process S) and circadian gating (Process C). In 
diurnal animals, during the day homeostatic sleep pressure continuously increases, while the 
circadian drive for wakefulness is initially increased and then reduced as night approaches. 
When the difference between the two surpasses a threshold, sleep entry occurs. Homeostatic 
pressure is relieved during sleep, while the circadian drive for activity begins to rise as 
morning approaches, facilitating exit from the sleep state. Based on [10].
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